On the Radar News
Most Popular On the Radar Story
Five biotech companies to watch
by Dr. Simos Simeonidis Poniard Pharmaceuticals (PARD Market Outperform) is expected to announce data from the Phase III SPEAR trial of picoplatin, its novel platinum compound for the treatment of... Read more...
Latest Headlines
- November 18, 2009
- October 14, 2009
- September 1, 2009
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
